Protocol to Assess the Severity of Acute Kidney Injury
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The principal objective is to safely determine if we can identify the severity of Acute
Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and
urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict
the course of AKI (recovery v. RRT v. death)